Pfizer Inc. is looking to sell its remaining stake in Covid-19 vaccine partner BioNTech SE, a remnant from one of the pandemic’s most lucrative collaborations.
Share
Read more
Bloomberg - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Company
Trending
Categories
© Bloombergnews. All rights resereved